Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on March 6, 2025
Bimini Capital Management Announces Fourth Quarter 2024 Results
GlobeNewswire
·
March 6, 2025
VERO BEACH, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB: BMNM), (“Bimini Capital,” “Bimini,” or the “Company”), today announced results of operations for the three-month period ended December 31, 2024. Fourth Quarter …
Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire
·
March 6, 2025
- Duchenne: Reported positive initial data from INSPIRE DUCHENNE trial of next-generation Duchenne gene therapy candidate, SGT-003; In mid-2025, Company plans to request a U.S. Food and Drug Administration (FDA) meeting to discuss potential accelerated …
Global Ship Lease Declares Quarterly Dividend on its 8.75% Series B Cumulative Redeemable Perpetual Preferred Shares
GlobeNewswire
·
March 6, 2025
ATHENS, Greece, March 06, 2025 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today that the Company’s Board of Directors has declared a cash dividend of $0.546875 per depositary share, each …
Clarus Reports Fourth Quarter and Full Year 2024 Results
GlobeNewswire
·
March 6, 2025
Fourth Quarter Sales of $71.4 million, Adjusted EBITDA of $4.4 million, and Free Cash Flow of $14.4 million Completed the Acquisition of RockyMounts, Expanding Adventure’s Bike-Rack Product Capabilities Globally SALT LAKE CITY, March 06, 2025 (GLOBE …
Comstock Announces Full Year 2024 Results
GlobeNewswire
·
March 6, 2025
VIRGINIA CITY, Nev., March 06, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced its full year 2024 results, 2024 summary achievements, and our 2025 business outlook. “As of today, we achieved all of …
Costco Wholesale Corporation Reports Second Quarter and Year-To-Date Operating Results For Fiscal 2025 and February Sales Results
GlobeNewswire
·
March 6, 2025
ISSAQUAH, Wash., March 06, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the second quarter (twelve weeks) and the first 24 weeks of fiscal 2025, ended February 16 …
VALHI DECLARES QUARTERLY DIVIDEND
GlobeNewswire
·
March 6, 2025
Dallas, Texas, March 06, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on March 28, 2025 to stockholders …
CooperCompanies Announces First Quarter 2025 Results
GlobeNewswire
·
March 6, 2025
SAN RAMON, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2025. Revenue increased 4% year-over-year to $964 …
KRONOS WORLDWIDE, INC. REPORTS FOURTH QUARTER 2024 RESULTS
GlobeNewswire
·
March 6, 2025
Dallas, Texas, March 06, 2025 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $13.2 million, or $.12 per share, in the fourth quarter of 2024 compared to a net loss of $5.3 million, or $.05 per share, in the fourth …
New study links sports gambling with alcohol-related risks over time
GlobeNewswire
·
March 6, 2025
Las Vegas, NV 89109, March 06, 2025 (GLOBE NEWSWIRE) -- A new longitudinal study published in JAMA Psychiatry finds that sports gambling frequency and alcohol-related problems are strongly associated over time, reinforcing concerns about the potential …
CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 6, 2025
- Continued progress with lead program, CX-2051 (EpCAM PROBODY® Topo-1 ADC), in Phase 1a study in advanced colorectal cancer with initial Phase 1a clinical data to be presented in 1H 2025 - - CX-801 (PROBODY® Interferon-alpha 2b) Phase 1a translational …
TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 6, 2025
Fourth Quarter Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024 Fourth Quarter Gross Profit Margin of 50.2%, up 140 basis points from 48.8% in the third quarter of 2024 Full Year 2024 Net Cash provided by continuing …
Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results
GlobeNewswire
·
March 6, 2025
– Enrollment completed in VIRAGE Phase 2b clinical trial of VCN-01 in metastatic pancreatic ductal adenocarcinoma (PDAC); topline data expected in Q2 2025 – – VCN-01 development bolstered by FDA award of Fast Track designation for the treatment of PDAC and …
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to March 9, 2025
GlobeNewswire
·
March 6, 2025
New York, NY, March 06, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on March 6, 2025, it caused to be deposited $60,000 …
Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 6, 2025
ORKA-001, targeting IL-23p19, Phase 1 trial ongoing, with pharmacokinetic (PK) data expected in 2H 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout in 2H 2026 that provides multiple opportunities to show differentiation over …
Hummingbird Resources PLC Files Early Warning Report
GlobeNewswire
·
March 6, 2025
LONDON, March 06, 2025 (GLOBE NEWSWIRE) -- Hummingbird Resources PLC (“Hummingbird”), a West African gold mining company, announced today that in connection with the implementation of a take-over of Hummingbird pursuant to the UK Takeover Code (the “Code …
Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook
GlobeNewswire
·
March 6, 2025
First-in-class oral selective SMARCA2 (BRM) inhibitor FHD-909 (LY4050784) continues enrollment in Phase 1 trial for SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population FHD-909 preclinical combination …
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 6, 2025
Full Year 2024 Net Loss of $48.8 Million Compared to Net Loss of $65.1 Million in 2023 Full Year 2024 Adjusted EBITDA of $46.2 Million Compared to $40.8 Million in 2023 Increased Quarterly and Annual Operational Cash Flow Compared to Prior Periods to $7.2 …
NextCure Provides Business Update and Reports Full Year 2024 Financial Results
GlobeNewswire
·
March 6, 2025
Completed cohort 1 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers in February 2025 and plan to initiate backfill cohorts in the second half of 2025 Cash of approximately $68.6 million expected to fund operations into the second half of 2026 …
Five Star Bank Appoints Eric Marks Chief Consumer Banking Officer
GlobeNewswire
·
March 6, 2025
WARSAW, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (NASDAQ: FISI), parent company of Five Star Bank (“Five Star” or the “Bank”) and Courier Capital, LLC, announced that Eric W. Marks has joined as Senior Vice President, Chief …